Structural analysis and biological effects of a neutral polysaccharide from the fruits of Rosa laevigata.

2′, 7′-Dichlorofluorescein diacetate (PubChem CID: 104913) 3-Amino, 4-aminomethyl-2′, 7′-difluorescein diacetate (PubChem CID: 2762646) Antitumor activity Chloroform (PubChem CID: 6212) Dimethyl sulfoxide (PubChem CID: 679) Immunoregulatory activity Methyl iodide (PubChem CID: 6328) Neutral polysaccharide Rosa laevigata Sodium borohydride (PubChem CID: 4311764) Sodium chloride (PubChem CID: 5234) Thiazolyl blue tetrazolium bromide (PubChem CID: 64965) Tricaine (PubChem CID: 261501) Trifluoroacetic acid (PubChem CID: 6422) Zebrafish xenograft model

Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
01 Aug 2021
Historique:
received: 03 11 2020
revised: 10 04 2021
accepted: 11 04 2021
entrez: 10 5 2021
pubmed: 11 5 2021
medline: 5 10 2021
Statut: ppublish

Résumé

A neutral water-soluble polysaccharide (RLP50-2) was extracted and purified from the fruits of Rosa laevigata. The absolute molecular weight was determined as 1.26 × 10

Identifiants

pubmed: 33966844
pii: S0144-8617(21)00467-7
doi: 10.1016/j.carbpol.2021.118080
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Immunologic Factors 0
Monosaccharides 0
Polysaccharides 0
Reactive Oxygen Species 0
Nitric Oxide 31C4KY9ESH

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118080

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Jiaojiao Zhang (J)

State Key Laboratory of Medicinal Chemistry Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, and Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, 300350, People's Republic of China.

Ziteng Song (Z)

State Key Laboratory of Medicinal Chemistry Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, and Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, 300350, People's Republic of China.

Ying Li (Y)

State Key Laboratory of Medicinal Chemistry Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, and Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, 300350, People's Republic of China.

Shaojie Zhang (S)

State Key Laboratory of Medicinal Chemistry Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, and Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, 300350, People's Republic of China.

Jiahe Bao (J)

State Key Laboratory of Medicinal Chemistry Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, and Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, 300350, People's Republic of China.

Honglin Wang (H)

State Key Laboratory of Medicinal Chemistry Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, and Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, 300350, People's Republic of China.

Caixia Dong (C)

Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnosis, School of Pharmacy, Tianjin Medical University, Tianjin, 300070, People's Republic of China.

Yasushi Ohizumi (Y)

Kansei Fukushi Research Institute, Tohoku Fukushi University, Sendai, 989-3201, Japan.

Jing Xu (J)

State Key Laboratory of Medicinal Chemistry Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, and Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, 300350, People's Republic of China. Electronic address: Xujing611@nankai.edu.cn.

Yuanqiang Guo (Y)

State Key Laboratory of Medicinal Chemistry Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, and Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, 300350, People's Republic of China. Electronic address: victgyq@nankai.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH